Press Room

The mission of AAPS is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

AAPS represents approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science-related research institutes worldwide.

AAPS hosts three major conferences each year: PharmSci 360, the National Biotechnology Conference, and the Summer Scientific Forum in addition to online learning opportunities. Peer-reviewed journals under the AAPS umbrella include The AAPS Journal, AAPS PharmSciTech, Pharmaceutical Research, and AAPS Open, a fully open-access publication. The AAPS Newsmagazine features scientific and career development articles for AAPS members.

AAPS Communications Manager Rebecca Stauffer can be reached at [email protected].

AAPS in the Media

Reflections and Forecasts with AAPSs Executive Director Tina Morris
February 2023
Rizwan Chaudhrey
RSK Life Science Media

Live With Chaudhrey with AAPS's Tina Morris at National Biotechnology Conference
April 24, 2023
Rizwan Chaudhrey
RSK Life Science Media

Considering Biologic Drug Development and Manufacturing Holistically
May 2, 2023
PharmTech Drug Solutions Podcast

Voices of Biotech Episode 4: Bristol Myers Squibb on the limited diversity of the hiring pool
May 10, 2023
Lottie Leinfellner
Voices of Biotech podcast

How Sunscreen Base Formulas Affect SPF and Mechanical Properties
May 10, 2023
Cosmetics & Toiletries

What You Need to Know to Launch a Biotech Startup
Joanna Smiley
May 11, 2023
BioSpace

New bioanalytical service lab: How Mercodia is helping to advance drug development
May 12, 2023
Select Science

Exploring common challenges in bioanalytical assay validation and development in cell and gene therapy products
May 30, 2023
Select Science

Using Metabolomics to Understand Rare Pediatric Diseases
August 8, 2023
LCGC

In Equal Measures: The Importance of Excipient Quality
September 2, 2023
PharmTech

Driving Dosage Form Developments 
September 28, 2023
PharmTech

How to train AI for drug development
October 6, 2023
Select Science

Roquette Announces Completion of Qualicaps Acquisition at AAPS PharmSci 360
October 25, 2023
PharmTech

Redesign Concepts Critical for Continuous Manufacturing (AAPS PharmSci 360)
October 31, 2023
PharmTech

AAPS PharmSci360 conference highlights 2023
November 1, 2023
Bioanalysis Zone

The Challenge of Raw Material Variation in Adopting Continuous Manufacturing (AAPS PharmSci 360)
November 1, 2023
PharmTech

A Look at How Excipient Suppliers Can Support Adoption of Continuous Manufacturing (AAPS PharmSci 360)
November 1, 2023
PharmTech

Addressing the Analytical Challenge of Meeting Quick Turnaround Times (AAPS PharmSci 360)
November 2, 2023
BioPharm International

Targeting Automation Advances to Meet Industry Needs (AAPS PharmSci 360)
November 2, 2023
BioPharm International

Ensuring the Next Generation of Analytical Experts (AAPS PharmSci 360)
November 3, 2023
BioPharm International

Key E&L Issues to Consider During Formulation (AAPS PharmSci 360)
November 3, 2023
PharmTech

Distinguishing E&L Testing for Combination Products (AAPS PharmSci 360)
November 6, 2023
BioPharm International

Discussing E&L Study Design Between ISO and USP (AAPS PharmSci 360)
November 6, 2023
PharmTech

The Need for New Bioanalysis Technology (AAPS PharmSci 360)
November 7, 2023
BioPharm International

Discussing Oligonucleotide Challenges in Analytics and Purification (AAPS PharmSci 360)
November 7, 2023
BioPharm International

Oligonucleotide-Enabling Technology Pushes Oligos to the Forefront (AAPS PharmSci 360)
November 8, 2023
BioPharm International

International Council for Harmonization updates Good Clinical Practice Guideline to enhance support for advanced data-driven technologies
November 17, 2023
Select Science

Resolian broadens horizons and expertise with its expansion into China
November 13, 2023
Select Science

Trusted bioanalytical experts to support your trials
November 13, 2023
Select Science

How disruptive technologies are replacing animal testing in toxicology applications
November 13, 2023
The Scientists' Channel

How to translate novel cell and gene therapies from discovery to clinical trials
November 21, 2023
The Scientists' Channel

The promise of single-cell multimodal analysis in cell and gene therapies
November 21, 2023
The Scientists' Channel

Best Practices For Preformulation In Drug Development
December 14, 2023
Andrei Blasko
Drug Discovery Online

AAPS Press Release Archive 

2020-2023

2023

Anurag Rathore, Ph.D., to Become Editor-in-Chief of The AAPS Journal

AAPS Recognizes Importance of Quality Throughout Pharmaceutical Continuum

New Career Development Ebook Released

AAPS Salary Survey Shows 6.7% Compensation Increase Since 2022

Drug Discovery and R&D Leader Addresses Transformational Leadership Skills

AAPS Supports Credible Science in Research Literature

Thomas Hartung, M.D., Ph.D., Toxicology Expert, Predicts Transformative Role for AI in Drug and Chemical Risk Assessment at AAPS PharmSci 360

AAPS Elevates Eight Members to Fellow Status

AAPS Announces 2023 Awards Recipients

PharmSci 360 Presents Research from Across Drug Discovery Delivery Pipeline

The AAPS Journal Impact Factor Grows from 3.6 to 4.5

AAPS Launches Summer Scientific Forum, July 10-13, in Minneapolis

The AAPS Journal Recognized by Springer Nature for Editorial Excellence

AAPS PharmSci 360 Opening and Closing Plenary Speakers Announced

AAPS Receives Fourth “50 Fastest Recognition”

2023 AAPS National Biotechnology Conference a Success

AAPS Offering Management Training for Pharma Scientists This Month

Joel Dudley, Ph.D, Biotechnology Expert and Venture Capitalist, to Discuss
Current Economic Environment at AAPS National Biotechnology Conference

Retraction Watch Co-Founder Ivan Oransky to Present AAPS Webinar,
“Retractions Are On The Rise, But Not Enough” 

AAPS Executive Director Tina Morris, Ph.D., Addressed Future of Quality
Control Testing at Waters Corporation “Fireside Chat” 

Trade Show Executive Magazine Recognizes AAPS PharmSci 360 as One of Its
“50 Fastest” Growing Trade Shows in the United States 

AAPS Recognizes National Ethics Awareness Month

2022

AAPS Addresses “Infodemic,” Scientific Credibility, and the Public On TV

AAPS and RX Reach Agreement for Scientific Programming Oversight of Interphex

Dr. Udit Batra, President and CEO of Waters Corporation Discusses the Business of Science at Pharmsci 360

AAPS Executive Director Tina Morris, Ph.D., to Provide Scientific Insights During Industry Webinar Sponsored by NASDAQ & Certara

Finding Private Equity in Today's Market for Pharma Research and Growth to be Discussed in live Panel in Boston 

2020 

Tina Morris, Ph.D., Named Executive Director of American Association of Pharmaceutical Scientists